As of May 21, 2025, Somalogic Inc (SLGC) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Somalogic Inc's Forward P/E to Peers
To better understand Somalogic Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Somalogic Inc (SLGC) | - |
| Mesa Laboratories Inc (MLAB) | 102.07 |
| Thermo Fisher Scientific Inc (TMO) | 18.01 |
Compared to its competitors, Somalogic Inc's Forward P/E is difficult to compare due to insufficient data.